Naveed Wagle

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

Human Wild-Type Tau Interacts with wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila

George R. Jackson, Martina Wiedau‐Pazos, Tzu‐Kang Sang et al. · Neuron · 2002 · 484 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Developmental Biology +10

Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity

Kevin Diao, Shelly X. Bian, David M. Routman et al. · Journal of Neuro-Oncology · 2018 · 83 citations · Full text

Neuro-oncology, Surgical Oncology, Radiation Therapy +9

Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects

Kevin Diao, Shelly X. Bian, David M. Routman et al. · Journal of neurosurgery · 2018 · 80 citations · Full text

Impact of 3,4-Dihydroxy-6-¹⁸F-Fluoro-l-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective

Franziska Walter, Timothy F. Cloughesy, Martin A. Walter et al. · Journal of Nuclear Medicine · 2012 · 53 citations · Full text